DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe01145 gB122Δ10-15 GHRRYFTFG HSV 19104014
DRAVPe01205 RJ1 KAKAKAKAKAKAKAKAKAKAK HSV 15498607
DRAVPe01206 RJ3 KAAKKAAKAAKKAAKWAKKAA HSV 15498607
DRAVPe01207 RJ5 AKKAAKKAKKAAKKAKKAAKK HSV 15498607
DRAVPe01208 RJ6 AKKAAKKAKKAAKKAKKWAKK HSV 15498607
DRAVPe01209 RJ7 AKKAWKKAKKAAKKAKKWAKK HSV 15498607
DRAVPe01210 RJ8 ARRAWRRARRAARRARRAARR HSV 15498607
DRAVPe01211 RJ9 ARRAKRRARRAARRARRKARR HSV 15498607
DRAVPe01212 RJ10 ARRAKRRARRAKRRARRKKRR HSV 15498607
DRAVPe01303 Human defensin-5 (HD-5; Defensin, alpha 5; Human, mammals, animals) ATCYCRTGRCATRESLSGVCEISGRLYRLCCR SARS-CoV-2,HSV,HIV 34206990,26206286,23269800
DRAVPe01304 HD5[E21R] ATCYCRTGRCATRESLSGVCRISGRLYRLCCR HSV,HIV 23269800
DRAVPe01305 HD5[S23R] ATCYCRTGRCATRESLSGVCEIRGRLYRLCCR HSV 23269800
DRAVPe01306 HD5[T7R] ATCYCRRGRCATRESLSGVCEISGRLYRLCCR HSV 23269800
DRAVPe01307 HD5[L16R] ATCYCRTGRCATRESRSGVCEISGRLYRLCCR HSV 23269800
DRAVPe01350 H2-(1-15) ECRSTSYAGAVVNDL HSV 3040743
DRAVPe01351 H2-(4-15) STSYAGAVVNDL HSV 3040743
DRAVPe01352 H2-(7-15) YAGAVVNDL HSV 3040743
DRAVPe01353 H2-(8-15) AGAVVNDL HSV 3040743
DRAVPe01354 H2-(9-15) GAVVNDL HSV 3040743
DRAVPe01355 H2-(10-15) AVVNDL HSV 3040743
DRAVPe01356 H2-(11-15) VVNDL HSV 3040743
DRAVPe01357 Ac-H2-(7-15) YAGAVVNDL HSV 3040743
DRAVPe01358 H2-(7-15) amide YAGAVVNDL HSV 3040743
DRAVPe01359 Ac-H2-(7-15) amide YAGAVVNDL HSV 3040743
DRAVPe01360 Ac-H2-(11-15) VVNDL HSV 3040743
DRAVPe01361 [Tyr9]H2-(9-15) YAVVNDL HSV 3040743
DRAVPe01362 Ac-[Tyr9]H2-(9-15) YAVVNDL HSV 3040743
DRAVPe01363 [Tyr8]H2-(8-15) YGAVVNDL HSV 3040743
DRAVPe01364 Ac-[Tyr8]H2-(8-15) YGAVVNDL HSV 3040743
DRAVPe01365 [Ala7]H2-(7-15) AAGAVVNDL HSV 3040743
First 1 2 3 4 5 Last